Unresectable Solitary Hepatocellular Carcinoma Not Amenable to Radiofrequency Ablation: Multicenter Radiology-Pathology Correlation and Survival of Radiation SegmentectomyMichaël Vouche, Riad Salem, Michaël Abécassis et al.|Hepatology|2014Cited by 311
Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000‐patient 15‐year experienceRiad Salem, Robert J. Lewandowski, Ahmed Gabr et al.|Hepatology|2017Cited by 235
Pretransplant Portal Vein Recanalization—Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein ThrombosisRiad Salem, Laura Kulik, Michaël Vouche et al.|Transplantation|2015Cited by 151
Prospective randomized pilot study of Y90 +/− sorafenib as bridge to transplantation in hepatocellular carcinomaLaura Kulik, Riad Salem, Michaël Vouche et al.|Journal of Hepatology|2014Cited by 92